Related Experiment Videos
Methicillin-resistant Staphylococcus aureus in community-acquired pyoderma
Umashankar Nagaraju1, Gopalkrishna Bhat, Maria Kuruvila
1Department of Dermatology, Kasturba Medical College, Mangalore, Karnataka State, India.
International Journal of Dermatology
|June 10, 2004
Summary
Methicillin-resistant Staphylococcus aureus (MRSA) is emerging in community-acquired infections in India. High nasal carriage rates of MRSA in pyoderma patients suggest a need for antimicrobial stewardship to curb its spread.
Area of Science:
- Microbiology
- Infectious Diseases
- Public Health
Background:
- Methicillin-resistant Staphylococcus aureus (MRSA) is a significant pathogen in healthcare settings and increasingly in the community.
- Reports of MRSA in community-acquired infections within India are infrequent, necessitating further investigation.
- Pyoderma represents a common community-acquired infection where MRSA may be prevalent.
Purpose of the Study:
- To determine the prevalence of MRSA in patients with community-acquired pyoderma.
- To assess the rate of Staphylococcus aureus nasal colonization in these patients.
- To understand the epidemiological link between nasal carriage and skin infections.
Main Methods:
- A study involving 250 patients with community-acquired pyoderma in South India.
- Collection of swabs from skin lesions and anterior nares for bacterial culture.
- Antimicrobial susceptibility testing using Kirby-Bauer disk diffusion, agar dilution, and agar screen methods.
Main Results:
- Staphylococcus aureus was isolated from 80.8% of pyoderma cases.
- Methicillin-resistant Staphylococcus aureus (MRSA) accounted for 10.9% of S. aureus isolates.
- Nasal colonization with S. aureus was found in 54.4% of patients, with 11.8% carrying MRSA.
Conclusions:
- The findings indicate the emergence of MRSA in community-acquired infections in the study region.
- A high rate of nasal carriage of S. aureus, including MRSA, may contribute to recurrent pyoderma.
- Implementing appropriate antimicrobial policies and judicious antibiotic use is crucial to control MRSA dissemination in the community.